Type 1 IFN deficiency in the absence of normal splenic architecture during lymphocytic choriomeningitis virus infection

Journal of Immunology

Volumn 177, Issue 5, 2006, Pages 3266-3272

  Louten, Jennifer ^a   Van Rooijen, Nico ^b   Biron, Christine A ^a  

^a BROWN UNIVERSITY   (United States)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLODRONIC ACID; GLYCOPROTEIN P 15095; INTERFERON; LIPOSOME; LYMPHOTOXIN; METALLOTHIONEIN; MU METALLOTHIONEIN; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNE SYSTEM; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; SCID MOUSE; SPLEEN; SPLEEN DEFECT; SPLEEN MARGINAL ZONE; T LYMPHOCYTE; VIRUS REPLICATION;

EID: 33747772707     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.5.3266     Document Type: Article

References (41)

1. Luft, T., K. C. Pang, E. Thomas, P. Hertzog, D. N. Hart, J. Trapani, and J. Cebon. 1998. Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 161: 1947-1953.
2. Montoya, M., G. Schiavoni, F. Mattei, I. Gresser, F. Belardelli, P. Borrow, and D. F. Tough. 2002. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 99: 3263-3271.
3. Dalod, M., T. Hamilton, R. Salomon, T. P. Salazar-Mather, S. C. Henry, J. D. Hamilton, and C. A. Biron. 2003. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon α/β. J. Exp. Med. 197: 885-898.
4. Tough, D. F., P. Borrow, and J. Sprent. 1996. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272: 1947-1950.
5. Marrack, P., J. Kappler, and T. Mitchell. 1999. Type I interferons keep activated T cells alive. J. Exp. Med. 189: 521-530.
6. Pien, G. C., K. B. Nguyen, L. Malmgaard, A. R. Satoskar, and C. A. Biron. 2002. A unique mechanism for innate cytokine promotion of T cell responses to viral infections. J. Immunol. 169: 5827-5837.
7. Nguyen, K. B., W. T. Watford, R. Salomon, S. R. Hofmann, G. C. Pien, A. Morinobu, M. Gadina, J. J. O'Shea, and C. A. Biron. 2002. Critical role for STAT4 activation by type 1 interferons in the interferon-γ response to viral infection. Science 297: 2063-2066.
8. Dalod, M., T. P. Salazar-Mather, L. Malmgaard, C. Lewis, C. Asselin-Paturel, F. Briere, G. Trinchieri, and C. A. Biron. 2002. Interferon α/β and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 195: 517-528.
9. Malmgaard, L., T. P. Salazar-Mather, C. A. Lewis, and C. A. Biron. 2002. Promotion of α/β interferon induction during in vivo viral infection through αβ interferon receptor/STAT1 system-dependent and -independent pathways. J. Virol. 76: 4520-4525.
10. Mebius, R. E., M. A. Nolte, and G. Kraal. 2004. Development and function of the splenic marginal zone. Crit. Rev. Immunol. 24: 449-464.
11. Leenen, P. J., K. Radosevic, J. S. Voerman, B. Salomon, N. van Rooijen, D. Klatzmann, and W. van Ewijk. 1998. Heterogeneity of mouse spleen dendritic cells: in vivo phagocytic activity, expression of macrophage markers, and sub-population turnover. J. Immunol. 160: 2166-2173.
12. Kraal, G. 1992. Cells in the marginal zone of the spleen. Int. Rev. Cytol. 132: 31-74.
13. Wang, B., C. Biron, J. She, K. Higgins, M. J. Sunshine, E. Lacy, N. Lonberg, and C. Terhorst. 1994. A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene. Proc. Natl. Acad. Sci. USA 91: 9402-9406.
14. van Rooijen, N., N. Kors, and G. Kraal. 1989. Macrophage subset repopulation in the spleen: differential kinetics after liposome-mediated elimination. J. Leukocyte Biol. 45: 97-104.
15. Van Rooijen, N., and A. Sanders. 1994. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174: 83-93.
16. Van Rooijen, N. 1989. The liposome-mediated macrophage 'suicide' technique. J. Immunol. Methods 124: 1-6.
17. Orange, J. S., and C. A. Biron. 1996. Characterization of early IL-12, IFN-αβ, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156: 4746-4756.
18. Hanson, L. K., J. S. Slater, Z. Karabekian, H. W. Virgin IV, C. A. Biron, M. C. Ruzek, N. van Rooijen, R. P. Ciavarra, R. M. Stenberg, and A. E. Campbell. 1999. Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis. J. Virol. 73: 5970-5980.
19. Oldstone, M. B. 2002. Biology and pathogenesis of lymphocytic choriomeningitis virus infection. Curr. Top. Microbiol. Immunol. 263: 83-117.
20. Fu, Y. X., and D. D. Chaplin. 1999. Development and maturation of secondary lymphoid tissues. Annu. Rev. Immunol. 17: 399-433.
21. Montoya, M., M. J. Edwards, D. M. Reid, and P. Borrow. 2005. Rapid activation of spleen dendritic cell subsets following lymphocytic choriomeningitis virus infection of mice: analysis of the involvement of type 1 IFN. J. Immunol. 174: 1851-1861.
22. Diebold, S. S., M. Montoya, H. Unger, L. Alexopoulou, P. Roy, L. E. Haswell, A. Al-Shamkhani, R. Flavell, P. Borrow, and C. Reis e Sousa. 2003. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 424: 324-328.
23. Eloranta, M. L., and G. V. Alm. 1999. Splenic marginal metallophilic macrophages and marginal zone macrophages are the major interferon-α/ β producers in mice upon intravenous challenge with herpes simplex virus. Scand. J. Immunol. 49: 391-394.
24. Feldman, S. B., M. Ferraro, H. M. Zheng, N. Patel, S. Gould-Fogerite, and P. Fitzgerald-Bocarsly. 1994. Viral induction of low frequency interferon-α producing cells. Virology 204: 1-7.
25. Gobl, A. E., K. Funa, and G. V. Alm. 1988. Different induction patterns of mRNA for IFN-α and -β in human mononuclear leukocytes after in vitro stimulation with herpes simplex virus-infected fibroblasts and Sendai virus. J. Immunol. 140: 3605-3609.
26. Muller, S., L. Hunziker, S. Enzler, M. Buhler-Jungo, J. P. Di Santo, R. M. Zinkernagel, and C. Mueller. 2002. Role of an intact splenic microarchitecture in early lymphocytic choriomeningitis virus production. J. Virol. 76: 2375-2383.
27. -/- donors to wild-type hosts: implications for the generation of architectural events in lymphoid B cell domains. J. Immunol. 161: 3836-3843.
28. Nolte, M. A., R. Arens, M. Kraus, M. H. van Oers, G. Kraal, R. A. van Lier, and R. E. Mebius. 2004. B cells are crucial for both development and maintenance of the splenic marginal zone. J. Immunol. 172: 3620-3627.
29. Pasparakis, M., S. Kousteni, J. Peschon, and G. Kollias. 2000. Tumor necrosis factor and the p55TNF receptor are required for optimal development of the marginal sinus and for migration of follicular dendritic cell precursors into splenic follicles. Cell. Immunol. 201: 33-41.
30. Oehen, S., B. Odermatt, U. Karrer, H. Hengartner, R. Zinkernagel, and C. Lopez-Macias. 2002. Marginal zone macrophages and immune responses against viruses. J. Immunol. 169: 1453-1458.
31. Seiler, P., P. Aichele, B. Odermatt, H. Hengartner, R. M. Zinkernagel, and R. A. Schwendener. 1997. Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection. Eur. J. Immunol. 27: 2626-2633.
32. Berger, D. P., D. Naniche, M. T. Crowley, P. A. Koni, R. A. Flavell, and M. B. Oldstone. 1999. Lymphotoxin-β-deficient mice show defective antiviral immunity. Virology 260: 136-147.
33. Suresh, M., G. Lanier, M. K. Large, J. K. Whitmire, J. D. Altman, N. H. Ruddle, and R. Ahmed. 2002. Role of lymphotoxin α in T-cell responses during an acute viral infection. J. Virol. 76: 3943-3951.
34. Kolumam, G. A., S. Thomas, L. J. Thompson, J. Sprent, and K. Murali-Krishna. 2005. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 202: 637-650.
35. Curtsinger, J. M., J. O. Valenzuela, P. Agarwal, D. Lins, and M. F. Mescher. 2005. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 174: 4465-4469.
36. Cella, M., M. Salio, Y. Sakakibara, H. Langen, I. Julkunen, and A. Lanzavecchia. 1999. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189: 821-829.
37. Lindahl, P., I. Gresser, P. Leary, and M. Tovey. 1976. Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells. Proc. Natl. Acad. Sci. USA 73: 1284-1287.
38. Gallucci, S., M. Lolkema, and P. Matzinger. 1999. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5: 1249-1255.
39. Santini, S. M., C. Lapenta, M. Logozzi, S. Parlato, M. Spada, T. Di Pucchio, and F. Belardelli. 2000. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. Exp. Med. 191: 1777-1788.
40. Probst, H. C., K. Tschannen, B. Odermatt, R. Schwendener, R. M. Zinkernagel, and M. Van Den Broek. 2005. Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells. Clin. Exp. Immunol. 141: 398-404.
41. Probst, H. C., and M. van den Broek. 2005. Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells. J. Immunol. 174: 3920-3924.